Genetic variation in the vaspin gene affects circulating serum vaspin concentrations

International Journal of Obesity

Volumn 37, Issue 6, 2013, Pages 861-866

  Breitfeld, J ^a   Tonjes A ^a   Bottcher Y ^a   Schleinitz, D ^a   Wiele, N ^a   Marzi, C ^b,c   Brockhaus, C ^b,d   Rathmann, W ^e   Huth, C ^b   Grallert, H ^b,c   Illig, T ^b,f   Bluher M ^a   Kovacs, P ^a   Stumvoll, M ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

GWAS; insulin resistance; serum vaspin concentrations; vaspin

Indexed keywords

VASPIN;

ADULT; ALLELE; ARTICLE; CHROMOSOME 14; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE MAPPING; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84882253920     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2012.133     Document Type: Article

References (26)

1. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-2556.
2. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A et al. Visceral adipose tissuederived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 2005; 102: 10610-10615.
3. Klö ting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schön MR et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun 2006; 339: 430-436.
4. Youn BS, Klö ting N, Kratzsch J, Lee N, Park JW, Song ES et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008; 57: 372-377.
5. Jeong E, Youn BS, Kim DW, Kim EH, Park JW, Namkoong C et al. Circadian rhythm of serum vaspin in healthy male volunteers: relation to meals. J Clin Endocrin Metab 2010; 95: 1869-1875.
6. Klö ting N, Kovacs P, Kern M, Heiker JT, Fasshauer M, Schön MR et al. Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects. Diabetologia 2011; 54: 1819-1823.
7. Tönjes A, Koriath M, Schleinitz D, Dietrich K, Bö ttcher Y, Rayner NW et al. Genetic variation in GPR133 is associated with height: genome wide association study in the self-contained population of Sorbs. Hum Mol Gen 2009; 18: 4662-4668.
8. Tönjes A, Zeggini E, Kovacs P, Bö ttcher Y, Schleinitz D, Dietrich K et al. Association of FTO variants with BMI and fat mass in the self-contained population of Sorbs in Germany. Eur J Hum Genet 2010; 18: 104-110.
9. Veeramah KR, Tönjes A, Kovacs P, Gross A, Wegmann D, Geary P et al. Genetic variation in the Sorbs of eastern Germany in the context of broader European genetic diversity. Eur J Hum Genet 2011; 19: 995-1001.
10. ADA. Standards of medical care in diabetes-2010. Diabetes Care 2010; 33: S11-S61.
11. Bö ttcher Y, Teupser D, Enigk B, Berndt J, Klö ting N, Schön MR et al. Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans. J Clin Endocrinol Metab 2006; 91: 2725-2731.
12. Böttcher Y, Unbehauen H, Klöting N, Ruschke K, Körner A, Schleinitz D et al. Adipose tissue expression and genetic variants of the bone morphogenetic protein receptor 1A gene (BMPR1A) are associated with human obesity. Diabetes 2009; 58: 2119-2128.
13. Wichmann HE, Gieger C, Illig T. KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 2005; 67: S26-S30.
14. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies via imputation of genotypes. Nat Genet 2007; 39: 906-913.
15. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
16. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010; 26: 2190-2191.
17. Stouffer SA, Suchman EA, DeVinney LC, Star SA, Williams Jr RM . Adjustment During Army Life. Princeton University Press: Princeton, NJ, 1949.
18. R Development Core Team. R: A language and environment for statistical computing, 2008.
19. de Bakker PIW, Yelensky R, Pé er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005; 37: 1217-1223.
20. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous longterm hyperglycemic rat with diabetic complications-Otsuka Long-Evans Tokushima fatty (Oletf) strain. Diabetes 1992; 41: 1422-1428.
21. Li Q, Chen R, Moriya J, Yamakawa J, Sumino H, Kanda T et al. A novel adipocytokine, visceral adipose tissue-derived serine protease inhibitor (vaspin), and obesity. J Int Med Res 2008; 36: 625-629.
22. Wada J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 2008; 17: 327-333.
23. Kempf K, Rose B, Illig T, Rathmann W, Strassburger K, Thorand B et al. Vaspin (SERPINA12) genotypes and risk of type 2 diabetes: results from the MONICA/KORA studies. Exp Clin Endocrinol Diab 2010; 118: 184-189.
24. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010; 42: 105-116.
25. Saxena R, Hivert MF, Langenberg C, Tanaka T, Pankow JS, Vollenweider P et al. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 2010; 42: 142-148.
26. Soranzo N, Sanna S, Wheeler E, Gieger C, Radke D, Dupuis J et al. Common variants at 10 genomic loci influence hemoglobin A(1C) levels via glycemic and nonglycemic pathways. Diabetes 2010; 59: 3229-3239.